Smartphone-Based Medical Detection
Tech ID
P24-1339
Patent Status
Granted in India
Design Status
--
Technical Description
This technology describes a device for quantifying glucose and antigen-antibody interaction in biological fluids using enhanced chemiluminescence (ECL) imaging.
Problems Addressed
- Expensive Detection Systems
- Complex Assay Procedures
- Limited In Vivo Compatibility
- Inefficient Glucose Monitoring
- Insufficient Sensitivity & Selectivity
- Non-Optimized Smartphone Integration
TARGET AUDIENCE
- Healthcare Sector
- Medical Device Industry
- Biotechnology & Life Sciences Industries
- Pharmaceutical & Diagnostic Industries
- Academic & Research Institutions
TECH FEATURES
- Enhanced Biological Fluid Analysis
- Efficient Smartphone-Based Detection
- Enhanced Analyte Detection
- Enhanced Glucose Detection
- Smartphone-Based ECL Quantification
P24-1339
Send download link to email.
Available For
Available for exclusive and non exclusive license
Sell off
Cost
—
Stage of Developments
Technology Validated
Contact Person
Mr. Lalit Ambastha
IP Bazzaar Technology Pvt. Ltd.
IP Bazzaar Technology Pvt. Ltd.
12 First Floor, National Park, Lajpat Nagar-IV,
New Delhi-110024, India
Tel: [+91] 11-26360036;
Fax: [+91] 11-26360037;
Mobile: [+91]9811367838;
Email: tech@ipbazzaar.com;
www.ipbazzaar.com
New Delhi-110024, India
Tel: [+91] 11-26360036;
Fax: [+91] 11-26360037;
Mobile: [+91]9811367838;
Email: tech@ipbazzaar.com;
www.ipbazzaar.com